One of the major issues associated with longer life expectancy in man and his best friend is an increase in the incidence of cancer. Even though they cannot talk it seems dogs might be able to tell us why and how certain cancers develop.
Sucampo Pharmaceuticals, Inc., (Sucampo Pharmaceuticals) today announced that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration to seek market approval of a lower strength of lubiprostone (8 mcg) to treat irritable bowel syndrome with constipation (IBS-C).
Bringing together the high-quality 3D images of MRI with the intense tumor-killing x-rays of a linear accelerator, scientists at the Alberta Cancer Board are building a prototype that could for the first time enable powerful x-ray beams to become a viable treatment option for liver, stomach and pancreatic cancers, which currently must be treated with surgery, drugs, or internal radioactive seeds in most cases.
Using innovative physics, researchers have proposed a system that may one day bring proton therapy, a state-of-the-art cancer treatment method currently available only at a handful of centers, to radiation treatment centers and cancer patients everywhere.
Eli Lilly and Company (NYSE: LLY) and Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) welcomed the recent decision by the Scottish Medicines Consortium (SMC) on the use of BYETTA(R) (exenatide) in Scotland.
Groin injury accounts for a large amount of lost playing time, especially in soccer players. A new study finds that a simple 20-minute warm-up program used during preseason averts these injuries.
Measuring levels of a chemical found in blood offers the best indicator yet of the amount of fat surrounding abdominal organs, according to a new study of lean and obese individuals reported in the July issue of Cell Metabolism, a publication of Cell Press.
A new study confirms that treatment of early stage lung cancer should not be delayed.
Chronic infection with the hepatitis C virus (HCV) is the leading reason patients receive liver transplants today. Unfortunately, infection of the new liver by residual HCV in the blood is inevitable, and the immune system suppression crucial to prevent transplant rejection can worsen HCV-mediated disease in transplant patients.
Anemia is one of the most frequent complications of hemodialysis, and its correction is an important factor in restoring a tolerable quality of life to dialysis-dependent patients.